Gholami Morteza, Asgarbeik Saeedeh, Razi Farideh, Esfahani Ensieh Nasli, Zoughi Marzieh, Vahidi Aida, Larijani Bagher, Amoli Mahsa Mohammad
Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
J Res Med Sci. 2020 Jun 30;25:56. doi: 10.4103/jrms.JRMS_751_19. eCollection 2020.
Type 2 diabetes mellitus (T2DM) is a metabolic disorder with growing prevalence and increasing economic burden. Based on the role of genetics and epigenetic factors on T2DM, we aimed to carry a systematic review and meta-analysis for all miRNA gene polymorphisms and risk of T2DM.
A computerized literature search was carried out on PubMed, Web of Science, Scopus, Embase, as well as references of relevant review/meta-analysis. Key search terms were "Diabetes Mellitus, Type 2," "MicroRNAs," and "Polymorphism, Single Nucleotide." All types of observational studies from January 1, 1992, to November 30, 2019, were included, without language restriction. Data analysis was performed using R programming language (3.5.2). Level of heterogeneity was obtained by Cochran's Q test ( < 0.05), and subgroup analysis was performed based on ethnicity.
Thirty-two polymorphisms from fifteen articles were included. Meta-analysis was carried out based on minor allele frequencies. Seven studies with 2193 cases and 3963 controls were included for rs2910164 polymorphism. In subgroup analysis, there were significant results in Caucasian population in dominant model (odds ratio [OR] =1.12; 95% confidence interval [CI]: 0.83-1.51), homozygote model (OR = 1.78; 95% CI: 1.06-3.00), heterozygote model (OR = 1.77; 95% CI: 1.03-3.05), and recessive model (OR = 1.78; 95% CI: 1.07-2.96). Four studies with 2085 cases and 1933 controls were included for rs895819 polymorphism. Overall, there was no significant result for association with rs895819, but subgroup analysis revealed that minor allele significantly decreased the risk of T2DM in Caucasians by recessive model (OR = 0.34; 95% CI: 0.18-0.66), dominant model (OR = 0.70; 95% CI: 0.52-0.94), homozygote model (OR = 0.32; 95% CI: 0.16-0.62), heterozygote model (OR = 0.37; 95% CI: 0.19-0.74), allelic model (OR = 0.67; 95% CI: 0.52-0.85).
The minor allele of rs2910164 may increase the risk of T2DM by leading to lower level of miR-146a. In contrast, minor allele of rs895819 may decrease the risk of T2DM by leading to higher level of miR-27a.
2型糖尿病(T2DM)是一种患病率不断上升且经济负担日益加重的代谢性疾病。基于遗传和表观遗传因素在T2DM中的作用,我们旨在对所有miRNA基因多态性与T2DM风险进行系统评价和荟萃分析。
在PubMed、Web of Science、Scopus、Embase以及相关综述/荟萃分析的参考文献中进行计算机文献检索。关键检索词为“2型糖尿病”“微小RNA”和“单核苷酸多态性”。纳入1992年1月1日至2019年11月30日期间的所有类型观察性研究,无语言限制。使用R编程语言(3.5.2)进行数据分析。通过Cochran's Q检验获得异质性水平(<0.05),并根据种族进行亚组分析。
纳入了15篇文章中的32个多态性。基于次要等位基因频率进行荟萃分析。rs2910164多态性纳入了7项研究,共2193例病例和3963例对照。在亚组分析中,白种人群在显性模型(比值比[OR]=1.12;95%置信区间[CI]:0.83-1.51)、纯合子模型(OR = 1.78;95% CI:1.06-3.00)、杂合子模型(OR = 1.77;95% CI:1.03-3.05)和隐性模型(OR = 1.78;95% CI:1.07-2.96)中有显著结果。rs895819多态性纳入了4项研究,共2085例病例和1933例对照。总体而言,与rs895819的关联无显著结果,但亚组分析显示,次要等位基因在白种人中通过隐性模型(OR = 0.34;95% CI:0.18-0.66)、显性模型(OR = 0.70;95% CI:0.52-0.94)、纯合子模型(OR = 0.32;95% CI:0.16-0.62)、杂合子模型(OR = 0.37;95% CI:0.19-0.74)、等位基因模型(OR = 0.67;95% CI:0.52-0.85)显著降低了T2DM风险。
rs2910164的次要等位基因可能通过导致miR-146a水平降低而增加T2DM风险。相反,rs895819的次要等位基因可能通过导致miR-27a水平升高而降低T2DM风险。